Drug Policy > Ketamine

Tracking since May 19, 2026 · Latest signal Apr 23, 2026 · 3 matched data points

Overall sentiment

Positive 0% (0)Negative 100% (3)Neutral 0% (0)

Daily sentiment

Claims (1)

Claims contributing to this aggregate. Confirmed negative claims count as negative impact; confirmed positive claims count as positive impact.

The compound CI-581, also known as ketamine, has transitioned from a medical analgesic to a recreational drug and is now being promoted as an antidepressant.

Parent: Drug PolicyEntity: KetamineImpact: negativeDate: Apr 23, 2026Target: The compound CI-581's role as a recreational drug and its use as an antidepressant.3 matched entries3 confirmed0 disputed0 neutral0 unclear